Goldman Sachs’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,012
| Closed | -$45.3K | – | 6372 |
|
|
2025
Q1 | $45.3K | Sell |
4,012
-4,256
| -51% | -$77.2K | ﹤0.01% | 5896 |
|
|
2024
Q4 | $169K | Buy |
8,268
+6,454
| +356% | +$188K | ﹤0.01% | 5685 |
|
|
2024
Q3 | $72K | Buy |
+1,814
| New | +$48.8K | ﹤0.01% | 5607 |
|
|
2021
Q3 | – | Sell |
-1,338
| Closed | -$134K | – | 6469 |
|
|
2021
Q2 | $134K | Buy |
1,338
+252
| +23% | +$26K | ﹤0.01% | 5874 |
|
|
2021
Q1 | $139K | Sell |
1,086
-222
| -17% | -$32.8K | ﹤0.01% | 5758 |
|
|
2020
Q4 | $145K | Buy |
1,308
+829
| +173% | +$92.8K | ﹤0.01% | 5194 |
|
|
2020
Q3 | $56K | Sell |
479
-6
| -1% | -$1.04K | ﹤0.01% | 5175 |
|
|
2020
Q2 | $104K | Buy |
485
+49
| +11% | +$11.6K | ﹤0.01% | 4985 |
|
|
2020
Q1 | $99K | Buy |
436
+108
| +33% | +$30.8K | ﹤0.01% | 4945 |
|
|
2019
Q4 | $88K | Buy |
328
+11
| +3% | +$2.77K | ﹤0.01% | 5061 |
|
|
2019
Q3 | $96K | Buy |
317
+21
| +7% | +$6.45K | ﹤0.01% | 4964 |
|
|
2019
Q2 | $98K | Sell |
296
-54
| -15% | -$27.4K | ﹤0.01% | 4926 |
|
|
2019
Q1 | $219K | Buy |
+350
| New | +$160K | ﹤0.01% | 4758 |
|
|
2018
Q4 | – | Sell |
-149
| Closed | -$69K | – | 5597 |
|
|
2018
Q3 | $69K | Sell |
149
-33
| -18% | -$16K | ﹤0.01% | 5229 |
|
|
2018
Q2 | $99K | Buy |
182
+74
| +69% | +$44.4K | ﹤0.01% | 5217 |
|
|
2018
Q1 | $62K | Sell |
108
-139
| -56% | -$87.7K | ﹤0.01% | 5412 |
|
|
2017
Q4 | $158K | Buy |
247
+133
| +117% | +$93.7K | ﹤0.01% | 5530 |
|
|
2017
Q3 | $107K | Buy |
114
+12
| +12% | +$9.18K | ﹤0.01% | 6036 |
|
|
2017
Q2 | $89K | Sell |
102
-15
| -13% | -$12.3K | ﹤0.01% | 6170 |
|
|
2017
Q1 | $80K | Sell |
117
-442
| -79% | -$291K | ﹤0.01% | 6157 |
|
|
2016
Q4 | $403K | Buy |
559
+391
| +233% | +$270K | ﹤0.01% | 5251 |
|
|
2016
Q3 | $124K | Buy |
+168
| New | +$136K | ﹤0.01% | 6119 |
|
|
2016
Q2 | – | Sell |
-59
| Closed | -$49K | – | 7211 |
|
|
2016
Q1 | $49K | Buy |
+59
| New | +$46.3K | ﹤0.01% | 6441 |
|
|
2015
Q4 | – | Sell |
-792
| Closed | -$671K | – | 7310 |
|
|
2015
Q3 | $671K | Buy |
792
+244
| +45% | +$354K | ﹤0.01% | 4854 |
|
|
2015
Q2 | $972K | Buy |
+548
| New | +$697K | ﹤0.01% | 4563 |
|
|
2015
Q1 | – | Sell |
-2,148
| Closed | -$2.43M | – | 7245 |
|
|
2014
Q4 | $2.43M | Buy |
2,148
+36
| +2% | +$36.9K | ﹤0.01% | 3649 |
|
|
2014
Q3 | $2.12M | Sell |
2,112
-346
| -14% | -$391K | ﹤0.01% | 3875 |
|
|
2014
Q2 | $3.24M | Buy |
2,458
+960
| +64% | +$1.15M | ﹤0.01% | 3485 |
|
|
2014
Q1 | $2.09M | Buy |
1,498
+1,182
| +374% | +$1.54M | ﹤0.01% | 3929 |
|
|
2013
Q4 | $363K | Buy |
316
+283
| +858% | +$390K | ﹤0.01% | 5545 |
|
|
2013
Q3 | $41K | Buy |
+33
| New | +$22.4K | ﹤0.01% | 6345 |
|
Other funds holding RMTI
AC
GC
Goldman Sachs's RMTI Position: Q2 2025 in Review
Goldman Sachs sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 4,012 shares — an estimated $45.3K sold.
Goldman Sachs first reported a position in RMTI in Q3 2013 and held it in 31 quarters. The position peaked at $3.24M in Q2 2014. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.
- Goldman Sachs reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
- Goldman Sachs sold 4,012 Rockwell Medical shares in Q2 2025, an estimated $45.3K.
- Goldman Sachs first reported a position in Rockwell Medical in Q3 2013 and held it in 31 quarters.
- Goldman Sachs's Rockwell Medical position peaked at $3.24M in Q2 2014.
- 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.
Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.